HI
NVO

Harbour Investments’s Novo Nordisk NVO Stock Holding History

Harbour Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
28,912
+5,128
+22% +$220K 0.02% 683
2026
Q1 		$874K Buy
23,784
+17,280
+266% +$819K 0.01% 816
2025
Q4 		$331K Sell
6,504
-1,587
-20% -$81.2K 0.01% 1038
2025
Q3 		$449K Sell
8,091
-46
-0.6% -$2.69K 0.01% 867
2025
Q2 		$562K Sell
8,137
-889
-10% -$60.5K 0.01% 733
2025
Q1 		$627K Buy
9,026
+12
+0.1% +$991 0.02% 640
2024
Q4 		$775K Sell
9,014
-2,118
-19% -$229K 0.02% 553
2024
Q3 		$1.33M Sell
11,132
-587
-5% -$78.3K 0.04% 385
2024
Q2 		$1.67M Buy
11,719
+3,188
+37% +$422K 0.06% 286
2024
Q1 		$1.1M Buy
8,531
+776
+10% +$92.4K 0.04% 392
2023
Q4 		$802K Buy
7,755
+1,199
+18% +$119K 0.03% 415
2023
Q3 		$596K Sell
6,556
-2
-0% -$176 0.03% 440
2023
Q2 		$531K Buy
6,558
+38
+0.6% +$3.1K 0.03% 478
2023
Q1 		$519K Buy
6,520
+100
+2% +$7.09K 0.03% 459
2022
Q4 		$434K Buy
6,420
+3,632
+130% +$213K 0.03% 492
2022
Q3 		$155K Hold
2,788
– – 0.01% 796
2022
Q2 		$155K Buy
+2,788
New +$155K 0.01% 796
2021
Q4 		$400K Sell
7,146
-7,880
-52% -$427K 0.02% 486
2021
Q3 		$721K Buy
15,026
+1,368
+10% +$66.1K 0.02% 525
2021
Q2 		$572K Buy
13,658
+8,688
+175% +$337K 0.02% 621
2021
Q1 		$168K Buy
+4,970
New +$177K 0.01% 1053

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Harbour Investments's NVO Position: Q2 2026 in Review

Harbour Investments increased its Novo Nordisk (NVO) stake by 22% in Q2 2026, buying an estimated $220K and bringing the position to 28,912 shares worth $1.39M. The position accounts for 0.02% of the portfolio, ranked #683.

Harbour Investments first reported a position in NVO in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.67M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Harbour Investments held 28,912 shares of Novo Nordisk worth $1.39M as of Q2 2026.
  • Harbour Investments bought 5,128 Novo Nordisk shares in Q2 2026, an estimated $220K.
  • Novo Nordisk made up 0.02% of Harbour Investments's portfolio in Q2 2026, its #683 holding.
  • Harbour Investments first reported a position in Novo Nordisk in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Novo Nordisk position peaked at $1.67M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.